Service

I am an elected Fellow of the American Statistical Association, lead PI of an NIH–NIGMS T32 training program in biostatistics, and former Director of UCI’s Data Science Initiative and Center for Statistical Consulting. I also serve as Associate Editor for several leading statistics journals.

Development & outreach

  • Director of the UCI Data Science Initiative, which offered workshops and organized symposia spanning computing, statistics, and data science.
  • Founder of the STEER program, providing PhD students with advanced training at the interface of biostatistics and biomedical sciences.
  • Established the SoCal Data Science program, which has mentored more than 90 undergraduate fellows from UCI, CSUF, and Cypress College.
  • Co-director of the Irvine Summer Institute in Biostatistics and Undergraduate Data Science (ISI-BUDS).
  • Contributed to Project PIPE-LINE, building data science pathways across UCI, CSUF, and community colleges.
  • Launched an annual data science summer school for high school students, sponsored by COSMOS.

Editorial & professional service

  • Panelist — more than 20 review panels for NSF and NIH · 2012–
  • Associate Editor, Journal of the American Statistical Association (Theory and Methods) · 2023–2026
  • Committee Member, UC-wide task force on Data Science · 2019–2020
  • Associate Editor, JASA/TAS · 2014–2020
  • Associate Editor, CHANCE · 2011–2020
  • Associate Editor, Statistical Analysis & Data Mining · 2012–2017
  • ISBA representative, JSM program council · 2019–2020
  • Lead Organizer, Statistical and Machine Learning Applications in Biomedical Sciences · 2024
  • Lead Organizer, NeuroDataScience · 2022
  • Co-organizer, Workshop on Big Data in Brain Science · 2017
  • Chair, IMS program at ENAR · 2016
  • Member, Scientific Review Committee · 2012–2014

Statistical consulting

Since 2009, I have worked as a statistical consultant for industry, primarily with clinical, diagnostics, and biotech companies. The work spans experimental design and power calculations for clinical trials, biomarker discovery, high-throughput data analysis, regression and classification modeling, nonparametric methods, longitudinal and survival analysis, and machine learning and deep learning.

Selected companies
General Atlantic ClearNote Health Myriad RBM Focus Diagnostics Allergan NeoGenomics Immumetrix Morphotek Alexion Veracyte Sera Prognostics